TAU scientist is first Israeli to win MetLife Award

Dr. Inna Slutsky receives illustrious award for outstanding research in the field of Alzheimer's disease.

12 September 2016

Tel Aviv University's Dr. Inna Slutsky won the 2016 MetLife Foundation Promising Investigator Award in Medical Research for Alzheimer's Disease from the American Foundation for Aging Research for her exemplary medical research in Alzheimer's disease. The award was presented on July 25, 2016, with the during the Alzheimer's Association International Conference in Toronto.

 

Dr. Slutsky, the first Israeli scientist to ever receive a MetLife Foundation Award, is a member of the Department of Physiology and Pharmacology at TAU's Sagol School of Neuroscience. She has focused her research on the breakdown of communication lines between brain cells in the pathology of Alzheimer's disease.

 

MetLife Foundation gave four awards this year, distributing a total of $350,000 to Dr. Slutsky; Guojun Bu, PhD, of the Mayo Clinic; Mia Kivipelto, MD, PhD, of Karolinska Institutet, Stockholm and Karolinska University Hospital, Stockholm; and John R. Cirrito, PhD, of Washington University School of Medicine. The awards recognize them as trail-blazing scientists who have made significant contributions to the understanding of Alzheimer's disease.

 

"Our Advisory Committee were so impressed by the potential impact of Dr. Slutsky and Dr. Cirrito's research that they granted them the Promising Investigator awards this year," said Dennis White, President and Chief Executive Officer, of MetLife Foundation at the awards ceremony.

 

"These four individuals have performed ground-breaking work, and the awards will help further their pioneering research," said past award recipient Dr. David M. Holtzman of Washington University School of Medicine during the ceremony. "Drs. Bu, Kivipelto, Slutsky, and Cirrito join a roster of past winners whose work has gone onto receive recognition in the field and beyond, including the Nobel Prize, the Potamkin Prize, and TIME Magazine's scientist of the year."

 

MetLife Foundation has been presenting these prestigious awards to outstanding researchers in the field of Alzheimer's disease for 30 years. Since 1986 it has granted more than $18 million to 88 awardees at 52 institutions in eight countries.

 

This article was originally published by AFTAU.

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>